Contact this trialFirst, we need to learn more about you.
Kinase Inhibitor
TT-00420 for Breast Cancer
Recruiting1 awardPhase 1
Houston, Texas
This trial is testing a new drug called TT-00420 for the treatment of triple negative breast cancer and other advanced solid tumors. The trial has two parts - one where they test different doses of the
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service